4Rizzo MR,Barbieri M,Marfella R,et al.Reduction of oxidative stress and inflammation by bluntingdaily acuteglucose fluctuations in patients with type 2 diabetes:role of dipeptidylpeptidase-Ⅳinhibition[J].Diabetes Care,2012,35(10):2076-2082.
5Lovshin JA,Drucker DJ.lncretin-based therapies for type 2 diabetes mellitus[J].Nat Rev Endocrinol,2009,5(5):262-269.
6Hayes MR,DE,Jonghe BC,Kanoski SE.Role of the glucapon-likeeptide-1 receptor in the control of energy balance[J].Physiol Behav,2010,100(5):503-510.
7Runge MS,Molnar K,Madamanchi NR.“Old”hearts and arteries:the role of oxidative stress[J].Trans Am Clin Climatol Assoc,2010,121(121):52-58.
8Kowluru RA,Tang J,Kern TS.Abnormalities of retinal metabolism in diabetes and experimental galactosemia.Ⅶ.Effect of long-term administration of antioxidants on the development of rentinopathy[J].Diabetes,2001,50(8):1938-1942.
9Woo HD,Kim BM,Kim YJ,et al.Quercetin prevents necrotic cell death induced by co-exposure to benzo(a)pyrene and UVA radiation[J].Toxicol In Vitro,2008,22(8):1840-1845.
10Mendivel A,Cuartero V,Mendivil MP.Ocular blood flow velocities in patients with proliferative diabetic retinopathy and healthy volunteers:a prospective study[J].Br J Opht halmol,1995,79(5):413-415.
